Search results
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
Investor's Business Daily· 2 years agoCrispr Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Friday,...
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
Zacks via Yahoo Finance· 2 months agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
CRISPR Therapeutics Stock: Bull vs. Bear
Motley Fool· 1 year agoCRISPR Therapeutics' (NASDAQ: CRSP) gene-editing technologies use the Cas9 enzyme as a mechanism for cutting a targeted piece out of DNA -- with the aim...
Here's Why CRISPR Therapeutics AG (CRSP) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 6 months agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 5 months agoCRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 11 months agoIn the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $57.75, marking a -0.81% move...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 6 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG CRSP reported a net loss per share of 67 cents in the first quarter of 2023,...
After This Landmark Win, Is CRISPR Therapeutics a Buy?
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) scored a major win in recent days, earning the world's first...
Why CRISPR Therapeutics Stock Is Marching Higher Today
Motley Fool· 1 year agoWhat happened Shares of CRISPR Therapeutics (NASDAQ: CRSP) are enjoying another strong session...
